Validating Type 1 and Type 2 Diabetes Mellitus in the Mini-Sentinel Distributed Database using the Surveillance PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) DataLink

Project Title Validating Type 1 and Type 2 Diabetes Mellitus in the Mini-Sentinel Distributed Database using the Surveillance PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) DataLink
Date Posted
Thursday, April 7, 2016
Status
Complete
Deliverables
Description

The purpose of this project was to conduct a validation study for Type 1 Diabetes Mellitus (T1DM) and Type 2 Diabetes Mellitus (T2DM) in the Mini-Sentinel Distributed Database (MSDD) using the SUrveillance, PREvention, and ManagEment of Diabetes Mellitus (SUPREME-DM) DataLink data from five Mini-Sentinel Data Partner sites that are also SUPREME-DM sites to examine the following two aims.

  • Aim 1: Demonstrate the feasibility of linking the MSDD and the SUPREME-DM DataLink.
  • Aim 2: Determine the sensitivity and positive predictive value (PPV) of the diagnosis codes and medication claims for patients with T1DM, T2DM, and any DM (e.g., inclusive of T1DM, T1DM, and DM of uncertain types) present in the MSDD, compared to the DataLink as the gold standard.
Workgroup Leader(s)

Marsha A. Raebel PharmD; Kaiser Permanente Colorado, Institute for Health Research, Denver, CO

Azadeh Shoaibi PhD, MHS, MS; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 

Workgroup Members

Carlos Bell, MPH; Aaron Niman; Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD 

Nikki Carroll MS; Glenn Goodrich MS; Andrea R. Paolino MA; John F. Steiner MD, MPH; Kaiser Permanente Colorado, Institute for Health Research, Denver, CO

Terese A. DeFor; Jody Jackson; Pam Pawloski PharmD; HealthPartners Institute for Education and Research, Minneapolis, MN

William Troy Donahoo; Colorado Permanente Medical Group Denver, CO

Sandra Feibelmann MPH; Candace Fuller PhD; Jennifer Popovic DVM, MA; Ryan M. Saliga; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA

Monica Fujii MPH; Katherine M. Newton PhD; Roy Pardee JD, MS; Group Health Research Institute, Seattle, WA

Jack Hamilton; Julie Schmittdiel PhD; Deanne Wiley; Kaiser Permanente Northern California, Division of Research, Oakland, CA

Gregory A Nichols PhD; Amanda Petrik MS; Daniel S. Sapp; Xiuhai Yang MS; Kaiser Permanente Northwest, Center for Health Research, Portland, OR

Emily B. Schroeder MD, PhD; Kaiser Permanente Colorado, Institute for Health Research and Colorado Permanente Medical Group, Denver, CO

Health Outcome
diabetes
type 1 diabetes mellitus
type 2 diabetes mellitus
Data Sources
Mini-Sentinel Distributed Database (MSDD)